Emerald Health Pharmaceuticals

Dr. Jim DeMesa is the Chief Executive Officer of Emerald Health Pharmaceuticals (“EHP”). Dr. DeMesa has 30 years of experience in biotechnology and pharmaceutical leadership, product development and clinical and regulatory management. He is a former practicing physician, CEO of two public biotech companies, and a board member of several biotech companies.

Emerald Health Pharmaceuticals is a clinical-stage biotech company developing unique therapies that combine biotechnology with cannabinoid science to fight Huntington’s disease and other diseases. The company’s mission is to change the treatment paradigm for various diseases which currently have no cure by developing a new class of medicine at the cutting-edge of cannabinoid science, designed to be potentially disease-modifying rather than just for symptomatic treatment.

Contact EHP:             info@emeraldpharma.life 
Website:                      https://emeraldpharma.life
Twitter:                        @Emerald__ Pharma
Facebook:                   @emeraldhealthpharmaceuticals
LinkedIn:                     Emerald Health Pharmaceuticals